TY - JOUR
T1 - Appropriate primary prevention of cardiovascular disease
T2 - Does this mean more or less statin use?
AU - Smith, Jane
PY - 2011
Y1 - 2011
N2 - Treatment with HMG-CoA reductase inhibitors, commonly known as statins, is beneficial for people at high risk of a cardiovascular event. However, guidelines recommend against routine statin treatment for those with a lower risk. They also recommend waiting until after 45 years of age to assess cardiovascular risk in healthy individuals. Aboriginal and Torres Strait Islander people should be assessed from age 35 years. These recommendations are based on current evidence of who is more likely to benefit from statin treatment.
AB - Treatment with HMG-CoA reductase inhibitors, commonly known as statins, is beneficial for people at high risk of a cardiovascular event. However, guidelines recommend against routine statin treatment for those with a lower risk. They also recommend waiting until after 45 years of age to assess cardiovascular risk in healthy individuals. Aboriginal and Torres Strait Islander people should be assessed from age 35 years. These recommendations are based on current evidence of who is more likely to benefit from statin treatment.
UR - http://www.scopus.com/inward/record.url?scp=82855175379&partnerID=8YFLogxK
U2 - 10.18773/austprescr.2011.085
DO - 10.18773/austprescr.2011.085
M3 - Article
AN - SCOPUS:82855175379
SN - 0312-8008
VL - 34
SP - 169
EP - 172
JO - Australian Prescriber
JF - Australian Prescriber
IS - 6
ER -
